These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23335130)

  • 1. Amelioration of systemic fibrosis in mice by angiotensin II receptor blockade.
    Marut W; Kavian N; Servettaz A; Hua-Huy T; Nicco C; Chéreau C; Weill B; Dinh-Xuan AT; Batteux F
    Arthritis Rheum; 2013 May; 65(5):1367-77. PubMed ID: 23335130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RhoA/Rho-kinase activation promotes lung fibrosis in an animal model of systemic sclerosis.
    Bei Y; Hua-Huy T; Nicco C; Duong-Quy S; Le-Dong NN; Tiev KP; Chéreau C; Batteux F; Dinh-Xuan AT
    Exp Lung Res; 2016; 42(1):44-55. PubMed ID: 26873329
    [TBL] [Abstract][Full Text] [Related]  

  • 3. iNOS Activity Is Required for the Therapeutic Effect of Mesenchymal Stem Cells in Experimental Systemic Sclerosis.
    Maria ATJ; Rozier P; Fonteneau G; Sutra T; Maumus M; Toupet K; Cristol JP; Jorgensen C; Guilpain P; Noël D
    Front Immunol; 2018; 9():3056. PubMed ID: 30622540
    [No Abstract]   [Full Text] [Related]  

  • 4. Propylthiouracil prevents cutaneous and pulmonary fibrosis in the reactive oxygen species murine model of systemic sclerosis.
    Bagnato G; Bitto A; Irrera N; Pizzino G; Sangari D; Cinquegrani M; Roberts W; Atteritano M; Altavilla D; Squadrito F; Bagnato G; Saitta A
    Arthritis Res Ther; 2013 Sep; 15(5):R120. PubMed ID: 24286160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The organotelluride catalyst (PHTE)₂NQ prevents HOCl-induced systemic sclerosis in mouse.
    Marut WK; Kavian N; Servettaz A; Nicco C; Ba LA; Doering M; Chéreau C; Jacob C; Weill B; Batteux F
    J Invest Dermatol; 2012 Apr; 132(4):1125-32. PubMed ID: 22277946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased exhaled nitric oxide precedes lung fibrosis in two murine models of systemic sclerosis.
    Hua-Huy T; Le-Dong NN; Duong-Quy S; Bei Y; Rivière S; Tiev KP; Nicco C; Chéreau C; Batteux F; Dinh-Xuan AT
    J Breath Res; 2015 Jun; 9(3):036007. PubMed ID: 26079155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Niclosamide Prevents Systemic Sclerosis in a Reactive Oxygen Species-Induced Mouse Model.
    Morin F; Kavian N; Nicco C; Cerles O; Chéreau C; Batteux F
    J Immunol; 2016 Oct; 197(8):3018-3028. PubMed ID: 27613696
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Th17 cells and IL-17 promote the skin and lung inflammation and fibrosis process in a bleomycin-induced murine model of systemic sclerosis.
    Lei L; Zhao C; Qin F; He ZY; Wang X; Zhong XN
    Clin Exp Rheumatol; 2016; 34 Suppl 100(5):14-22. PubMed ID: 26750756
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sunitinib inhibits the phosphorylation of platelet-derived growth factor receptor β in the skin of mice with scleroderma-like features and prevents the development of the disease.
    Kavian N; Servettaz A; Marut W; Nicco C; Chéreau C; Weill B; Batteux F
    Arthritis Rheum; 2012 Jun; 64(6):1990-2000. PubMed ID: 22213155
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dual αvβ3 and αvβ5 blockade attenuates fibrotic and vascular alterations in a murine model of systemic sclerosis.
    Bagnato GL; Irrera N; Pizzino G; Santoro D; Roberts WN; Bagnato G; Pallio G; Vaccaro M; Squadrito F; Saitta A; Altavilla D; Bitto A
    Clin Sci (Lond); 2018 Jan; 132(2):231-242. PubMed ID: 29237724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antifibrotic, Antioxidant, and Immunomodulatory Effects of Mesenchymal Stem Cells in HOCl-Induced Systemic Sclerosis.
    Maria AT; Toupet K; Bony C; Pirot N; Vozenin MC; Petit B; Roger P; Batteux F; Le Quellec A; Jorgensen C; Noël D; Guilpain P
    Arthritis Rheumatol; 2016 Apr; 68(4):1013-25. PubMed ID: 26474311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Fibrosis and Immunological Features of Hypochlorous Acid Induced Mouse Model of Systemic Sclerosis.
    Meng M; Tan J; Chen W; Du Q; Xie B; Wang N; Zhu H; Wang K
    Front Immunol; 2019; 10():1861. PubMed ID: 31481954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superiority of systemic bleomycin to intradermal HOCl for the study of interstitial lung disease.
    Morozan A; Joy S; Fujii U; Fraser R; Watters K; Martin JG; Colmegna I
    Sci Rep; 2023 Nov; 13(1):20577. PubMed ID: 37996447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrosis Development in HOCl-Induced Systemic Sclerosis: A Multistage Process Hampered by Mesenchymal Stem Cells.
    Maria ATJ; Toupet K; Maumus M; Rozier P; Vozenin MC; Le Quellec A; Jorgensen C; Noël D; Guilpain P
    Front Immunol; 2018; 9():2571. PubMed ID: 30455706
    [No Abstract]   [Full Text] [Related]  

  • 15. Simvastatin prevents vascular complications in the chronic reactive oxygen species murine model of systemic sclerosis.
    Bitto A; Bagnato GL; Pizzino G; Roberts WN; Irrera N; Minutoli L; Russo G; Squadrito F; Saitta A; Bagnato GF; Altavilla D
    Free Radic Res; 2016; 50(5):514-22. PubMed ID: 26846205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acazicolcept (ALPN-101), a dual ICOS/CD28 antagonist, demonstrates efficacy in systemic sclerosis preclinical mouse models.
    Orvain C; Cauvet A; Prudent A; Guignabert C; Thuillet R; Ottaviani M; Tu L; Duhalde F; Nicco C; Batteux F; Avouac J; Wang N; Seaberg MA; Dillon SR; Allanore Y
    Arthritis Res Ther; 2022 Jan; 24(1):13. PubMed ID: 34986869
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of irbesartan on the antioxidant defence system and nitric oxide release in diabetic rat kidney.
    Anjaneyulu M; Chopra K
    Am J Nephrol; 2004; 24(5):488-96. PubMed ID: 15353911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CX3CL1 (fractalkine) monoclonal antibody attenuates lung and skin fibrosis in sclerodermatous graft-versus-host disease mouse model.
    Hasegawa T; Utsunomiya A; Chino T; Kasamatsu H; Shimizu T; Matsushita T; Obara T; Ishii N; Ogasawara H; Ikeda W; Imai T; Oyama N; Hasegawa M
    Arthritis Res Ther; 2024 May; 26(1):94. PubMed ID: 38702742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leflunomide prevents ROS-induced systemic fibrosis in mice.
    Morin F; Kavian N; Chouzenoux S; Cerles O; Nicco C; Chéreau C; Batteux F
    Free Radic Biol Med; 2017 Jul; 108():192-203. PubMed ID: 28365359
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the cannabinoid pathway limits the development of fibrosis and autoimmunity in a mouse model of systemic sclerosis.
    Servettaz A; Kavian N; Nicco C; Deveaux V; Chéreau C; Wang A; Zimmer A; Lotersztajn S; Weill B; Batteux F
    Am J Pathol; 2010 Jul; 177(1):187-96. PubMed ID: 20508030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.